Changes in CpG methylation levels in individuals with AN compared to healthy controls could affect expression of the STAT3 gene and therefore the leptin signaling pathway, leading to impaired regulation of appetite and energy balance and thus to metabolic or eating disorders. The gene discussed is STAT3; the disease is eating disorder.